Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Trans R Soc Trop Med Hyg ; 95(6): 611-7, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11816432

RESUMO

Acute haemolysis associated with clinical episodes of high-level Plasmodium falciparum parasitaemia was studied in 20 children from an holoendemic area (coastal Tanzania). The change in blood haemoglobin (Hb) concentration ranged from -46 to g/L during the 72-h observation period and was linearly related to maximum parasitaemia. Balance studies between loss of blood Hb, increase in plasma Hb and appearance of Hb in the urine indicated that extravascular clearance of red cells was the predominant mode of erythrocyte clearance. Most subjects, however, showed minor signs of intravascular haemolysis. The plasma Hb was << 1% of blood Hb and haemoglobinuria was detected in 14/20 children but the excretion of Hb in urine was < 0.5% of total Hb loss. Haemoglobinuria was, however, a marker of severe haemolysis, since the maximum blood Hb loss in children without haemoglobinuria was 10 g/L. Erythrocyte-bound opsonins known to induce erythrophagocytosis, i.e., complement C3c fragments and autologous IgG, were increased in all patients. In the patients with major haemolysis, the changes correlated to the haemolysis over time. Hence, a similar mechanism for predominantly extravascular erythrocyte clearance may be operative in acute malarial anaemia, normal erythrocyte senescence and other forms of acute haemolysis.


Assuntos
Hemólise/fisiologia , Malária Falciparum/sangue , Doença Aguda , Pré-Escolar , Complemento C3c/análise , Eritrócitos/metabolismo , Feminino , Seguimentos , Haptoglobinas/análise , Hemoglobinas/análise , Hemoglobinúria/sangue , Hemoglobinúria/parasitologia , Hemopexina/análise , Humanos , Imunoglobulina G/sangue , Lactente , Malária Falciparum/complicações , Masculino , Parasitemia/sangue , Parasitemia/complicações
2.
Hepatology ; 31(4): 997-1004, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10733558

RESUMO

The antiviral drug ribavirin (RBV) is widely used in combination with interferon (IFN) in the treatment of chronic hepatitis C virus (HCV) infection. A major side effect of RBV is a reversible hemolytic anemia. We have evaluated the in vitro effects of RBV on erythrocyte adenosine triphosphate (ATP) content and on hexosemonophosphate shunt (HMS). The ATP levels were significantly decreased in the presence of RBV and the HMS was increased, suggesting the presence of red cell susceptibility to oxidation. In vivo, we have studied the hematologic effects of treatment with RBV alone or in combination with IFN in 11 patients with chronic hepatitis C: 6 were treated with RBV (1,000-1,200 mg/d) and 5 were treated with a combination of RBV and IFN (5 million U thrice weekly). Patients were studied at semi-monthly intervals from 0 to day 60 of therapy. Both treatments were associated with a significant reduction in hemoglobin levels (steady state level at day 45) and a marked increase in absolute reticulocyte counts. Erythrocyte Na-K pump activity was significantly diminished, whereas K-Cl cotransport and its dithiotreitol-sensitive fraction, malondialdehyde and methemoglobin levels were significantly increased. RBV-treated patients showed an increase in aggregated band 3, which was associated with a significantly increased binding of autologous antibodies and complement C3 fragments indicating an erithrophagocytic removal by reticuloendothelial system.


Assuntos
Anemia Hemolítica/induzido quimicamente , Antivirais/efeitos adversos , Membrana Eritrocítica , Hepatite C Crônica/tratamento farmacológico , Estresse Oxidativo , Ribavirina/efeitos adversos , Simportadores , Trifosfato de Adenosina/sangue , Adulto , Anemia Hemolítica/sangue , Proteína 1 de Troca de Ânion do Eritrócito/metabolismo , Antivirais/uso terapêutico , Proteínas de Transporte/sangue , Complemento C3/metabolismo , Membrana Eritrocítica/imunologia , Feminino , Hemoglobinas/metabolismo , Humanos , Imunoglobulina G/sangue , Interferons/uso terapêutico , Masculino , Pessoa de Meia-Idade , Contagem de Reticulócitos , Ribavirina/uso terapêutico , ATPase Trocadora de Sódio-Potássio/sangue , Cotransportadores de K e Cl-
3.
FEBS Lett ; 424(3): 257-61, 1998 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-9539162

RESUMO

Plasmodium falciparum parasites grew normally in glutathione (GSH)-depleted normal and G6PD-deficient (Mediterranean variant) erythrocytes (RBC). Growth inhibition was observed only at less than approximately 6-12% residual GSH. Parasites studied separately with the Sendai virus technique synthesized GSH de novo and regenerated reduced GSH 10-20 times faster than non-parasitized RBC. Electron spin resonance measurement of Tempol reduction indicated that the ability to reduce free radicals was restricted to the parasite. The marked efflux of oxidized GSH was mainly derived from the parasite. In conclusion, parasites are endowed with powerful and host-independent mechanisms which de novo synthesize or regenerate GSH and allow undisturbed parasite development in GSH-depleted RBC.


Assuntos
Eritrócitos/metabolismo , Eritrócitos/parasitologia , Glutationa/metabolismo , Plasmodium falciparum/metabolismo , Animais , Compartimento Celular , Eritrócitos/fisiologia , Deficiência de Glucosefosfato Desidrogenase/genética , Interações Hospedeiro-Parasita , Humanos , Masculino , Oxirredução , Plasmodium falciparum/crescimento & desenvolvimento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...